Andrea Trembath, MD, MPH of the Division of Neonatal-Perinatal Medicine is leading UNC-Chapel Hill’s involvement in the GEMINI Study. This multi-center, prospective clinical trial is designed to evaluate the clinical and economic utility of performing rapid whole genomic sequencing (vs. targeted genomic sequencing panels) in neonates and infants with suspected genetic disorders. As costs and turn-around times associated with whole genome sequencing continue to decrease, these technologies have an ever expanding capacity to aid in diagnosis and allow for earlier interventions in children with rare genetic disorders. Dr. Trembath received notification this week that enrollment can begin here at UNC. Read more >>